Skip to main content
SpringerLink
Log in
Book cover

Principles of Diabetes Mellitus pp 367–384Cite as

Diabetic Neuropathy

  • Chapter

  • 395 Accesses

Abstract

Diabetes mellitus (DM) is the most common cause of peripheral neuropathy in the United States. Approximately 16 million Americans suffer from diabetes and as many as 100% may have neuropathy. Evidence suggests that the incidence of neuropathy increases with the duration and severity of disease, and that strict glycemic control delays its development and progression. 1,2

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986, 1993.

    Google Scholar 

  2. Melton LJ III, Dyck PJ. Epidemiology, 239–252. in Dyck PJ, Thomas PK, et al (eds): Diabetic Neuropathy. WB Saunders, Philadelphia, 1999.

    Google Scholar 

  3. Thomas PK, Tomlinson DR: Diabetic and hypoglycemic neuropathy. p. 1219–1250. in Dyck PJ, Thomas PK, et al (eds). Peripheral Neuropathy. W.B. Saunders, Philadelphia, 1993.

    Google Scholar 

  4. Dyck PJ, Karnes JL, O’Brien PC, et al. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 42: 1164–70, 1992.

    Article  PubMed  CAS  Google Scholar 

  5. Pirart J. Diabetes Mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188, 1978.

    Google Scholar 

  6. Boulton Andrew JM, Malik RA. Diabetic Neuropathy. Medical Clinics of North America 82: 909–929, 1998.

    Article  PubMed  CAS  Google Scholar 

  7. Vinik AL, Park TS, et al. Diabetic neuropathies. Diabetologia 43: 957–973, 2000.

    Article  PubMed  CAS  Google Scholar 

  8. Halar EM, Graf RJ, Halter JB, Brozovich FV, Soine TL. Diabetic neuropathy: a clinical, laboratory, and electrodiagnostic study. Arch Phys Med Rehabil 63: 298–303, 1982.

    PubMed  CAS  Google Scholar 

  9. Niakan E, Harati Y. Sympathetic skin response in diabetic peripheral neuropathy. Muscle Nerve 11: 261–264, 1988.

    Article  PubMed  CAS  Google Scholar 

  10. Blau, RH. Diabetic Neuropathic Cachexia: Report of a Woman with this syndrome and review of the literature. Arch Intern Med 143: 2011–2012, 1983.

    Article  PubMed  CAS  Google Scholar 

  11. Archer AG, Watkins PJ, Thomas PK, et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 46: 491, 1983.

    Article  PubMed  CAS  Google Scholar 

  12. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 49: 95–108, 1980.

    PubMed  CAS  Google Scholar 

  13. Aronson D. Pharmacologic modulation of autonomic tone: implications for the diabetic patient. Diabetologia 40: 476–481, 1997.

    Article  PubMed  CAS  Google Scholar 

  14. Schnell O, Schwarz A, Becker DM, Standl E. Autoantibodies against autonomic nervous tissues in type 2 diabetes. Exp Clin Endocrinol Diabetes (Germany) 108: 181–6, 2000.

    Article  CAS  Google Scholar 

  15. Wein TH, Albers JW. Diabetic neuropathies. Phys Med and Rehab Clinics of North America 12 (2): 307–320, 2001.

    CAS  Google Scholar 

  16. Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland Syndrome (Diabetic Amyotrophy): Revisited 100 Years Later. Arch Neurol 48: 1130–1135, 1991.

    Article  PubMed  CAS  Google Scholar 

  17. Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc 72: 1123–1132, 1997.

    Article  PubMed  CAS  Google Scholar 

  18. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 35: 559–569, 1994.

    Article  PubMed  CAS  Google Scholar 

  19. Stewart JD. Diabetic truncal neuropathy: Topography of the sensory deficit. Ann Neurol 25: 233–238, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Sun SF, Streib EW. Diabetic thoracoabdominal neuropathy: Clinical and electrodiagnostic features. Ann Neurol 9: 75–79, 1981.

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 64: 592, 1960.

    Article  PubMed  CAS  Google Scholar 

  22. Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol 116: 723–727, 1998.

    Article  PubMed  CAS  Google Scholar 

  23. Richards BW, Jones FR, Younge BR. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol 113: 489–496, 1992.

    PubMed  CAS  Google Scholar 

  24. Dahlin LB, Meiri KF, McLean WG, et al. Effects of nerve compression on fast axonal transport in streptozotocin-induced diabetes mellitus. Diabetologica 29: 181–185, 1986.

    Article  CAS  Google Scholar 

  25. Shahani B, Spalding JMK. Diabetes mellitus presenting with bilateral foot-drop. Lancet 2: 930–931, 1969.

    Article  PubMed  CAS  Google Scholar 

  26. Dyck PJ, Sherman WR, Hallcher LM et al. Human diabetic endoneurial sorbitol, fructose, and myoinositol related to sural nerve morphometry. Ann Neurol. 8: 590–6, 1980.

    Article  PubMed  CAS  Google Scholar 

  27. Airey M, Bennet C, Nicolucci A, Williams R. Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev 285 (2):CD002182, 2000.

    Google Scholar 

  28. Newrick PG, Wilson AJ, Jakubowski J, et al. Sural nerve oxygen tension in diabetes. Brit Med J 293: 1053–1054, 1986.

    Article  CAS  Google Scholar 

  29. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950, 1984.

    Article  PubMed  Google Scholar 

  30. Low PA, Tuck RR, Dyck PJ, et al. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81: 6894–6898, 1984.

    Article  PubMed  CAS  Google Scholar 

  31. Low PA, Schmelzer JD, Ward KK, et al. Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol 99: 201–212, 1988.

    Article  PubMed  CAS  Google Scholar 

  32. Watkins PJ, Gayle C, Alsanjari N, et al. Severe sensory autonomic neuropathy and endocrinopathy in insulin dependent diabetes. Q J Med 88: 795–804, 1999.

    Google Scholar 

  33. Kelkar P, Masood M, Parry GJ. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 55: 83–88, 2000.

    Article  PubMed  CAS  Google Scholar 

  34. Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice, 3rd Ed. Oxford University Press, New York. 2001.

    Google Scholar 

  35. Low PA, Dotson RM. Symptomatic Treatment of Painful Neuropathy. JAMA 280: 1863–1864, 1998.

    Article  PubMed  CAS  Google Scholar 

  36. Max MB, Lynch SA, Muir J et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 (19): 1250–1256, 1992.

    Article  PubMed  CAS  Google Scholar 

  37. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 55: 915–920, 2000.

    Article  PubMed  CAS  Google Scholar 

  38. Bennet GJ, Dworkin RH, Nicholson B. Anticonvulsant Therapy in the Treatment of Neuropathic Pain. Neurology Treatment Updates. Medscape. www.medscape.com. Accessed May 9, 2001

    Google Scholar 

  39. Tremont-Lukats IW, Megeff C, Backonja M-M. Anticonvulsants for Neuropathic Pain Syndromes: Mechanisms of action and place in therapy. Drugs 60 (5): 1029–1052, 2000.

    Article  PubMed  CAS  Google Scholar 

  40. Gorson KC, Schott C, Herman R, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 66: 251–252, 1999.

    Article  PubMed  CAS  Google Scholar 

  41. McCleane G. Two hundred mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo controlled trial. Pain 83: 105–107, 1999.

    Article  PubMed  CAS  Google Scholar 

  42. Jarvis B, Coukell AJ. Mexiletine: a review of its therapeutic use in painful diabetic neuropathy. Drugs 56 (4): 691–707, 1998.

    Article  PubMed  CAS  Google Scholar 

  43. Rains C, Bryson HM. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7 (4): 317–328, 1995.

    Article  PubMed  CAS  Google Scholar 

  44. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50 (6): 1842–1846, 1998.

    Article  PubMed  CAS  Google Scholar 

  45. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol 38: 869–880, 1995.

    Google Scholar 

  46. Feldman EL, Stevens MJ, Greene DA. Clinical management of diabetic neuropathy: an overview. In Veves A (ed): Clinical Management of Diabetic Neuropathy. Humana Press, Totowa, NJ, 1998.

    Google Scholar 

Download references

Authors
  1. Russell Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Beth Israel Medical Center, New York, New York, USA

    Leonid Poretsky M.D. (Chief, Professor of Medicine) (Chief, Professor of Medicine)

  2. Albert Einstein College of Medicine, New York, New York, USA

    Leonid Poretsky M.D. (Chief, Professor of Medicine) (Chief, Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chin, R., Rubin, M. (2004). Diabetic Neuropathy. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6260-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6260-0_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6262-4

  • Online ISBN: 978-1-4757-6260-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation